Coreceptor switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange

Virology

Volumn 300, Issue 2, 2002, Pages 205-216

  Steidl, Stefanie ^a   Stitz, Jörn ^a   Schmitt, Isabel ^a   König, Renate ^a   Flory, Egbert ^a   Schweizer, Matthias ^a   Cichutek, Klaus ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Retroviral pseudotype vectors; SIV coreceptor usage; SIVagm; V3 loop exchange

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MEMBRANE PROTEIN; RETROVIRUS VECTOR; VIRUS ENVELOPE PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS NEUTRALIZATION;

CERCOPITHECUS AETHIOPS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MURINE LEUKEMIA VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0036387385     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1565     Document Type: Article

References (58)

1. Baier, M., Werner, A., Cichutek, K., Garber, C., Müller, C., Kraus, G., Ferdinand, F. J., Hartung S., Papas, T. S., and Kurth R. (1989). Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivo. J. Virol. 63, 5119-5123.
2. Blanco, J., Cabrera, C., Jou, A., Ruiz, L., Clotet, B., and Este, J. A. (1999). Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy. AIDS 13, 547-555.
3. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., and Mackay, C. R. (1997). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1939.
4. Burton, D. R. (1997). A vaccine for HIV type 1: The antibody perspective. Proc. Natl. Acad. Sci. USA 94, 10018-10023.
5. Cecilia, D., KewalRamani V. N., O'Leary, J., Volsky, B., Nyambi, P., Burda, S., Xu, S., Littman, D. R., and Zolla-Pazner, S. (1998). Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72, 6988-6996.
6. Chen, Z., Zhou, P., Ho, D. D., Landau, N. R., and Marx, P. A. (1997). Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71, 2705-2714.
7. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., Larosa, G., Newman, W., Gerard, N., Gerard, C., and Sodorski, J. (1996). The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
8. Cichutek, K., Merget, H., Norley, S., Linde, R., Kreuz, W., Gahr, M., and Kurth, R. (1992). Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc. Natl. Acad. Sci. USA 89, 7365-7369.
9. Cosset, F.-L., Tackeuchi, Y., Battini, J.-L., Weiss, R. A., and Collins, M. K. I. (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
10. Costello, E., Munoz, M., Buetti, E., Meylan, P. R. A., Diggelmann, H., and Thali, M. (2000). Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Therapy 7, 596-604.
11. Dejucq, N., Simmons, G., and Clapham, P. R. (1999). Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T cell lines determined by the capacity to exploit low concentrations of CCR5. J. Virol. 73, 7842-7847.
12. Deng, H. K., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Dimarzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., and Landau, N. R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
13. Deng, H. K., Unutmaz, D., Kewal-Ramani, V. N., and Littman, D. R. (1997). Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300.
14. Edinger, A. L., Hoffman, T. L., Sharron, M., Lee, B., O'Dowd, B., and Doms, R. W. (1998). Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 249, 367-378, doi: 10.1006/viro.1998.9306.
15. Edinger A. L., Ahuja M., Sung T., Baxter K. C., Haggarty B., Doms R. W., and Hoxie J. A. (2000). Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J. Virol. 74, 7922-7935.
16. Fehse, B., Schade, U. M., Zhixiong, L., Uhde, A., Koch, S., Goller, B., Rüger, R., Fehse, N., Stockschläder, M., and Zander, A. R. (1998). Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin. Br. J. Haemotol. 102, 566-574.
17. Ferry N., Duplessis O., Houssin D., Danos O., and Heard J. M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
18. Glamann, J., Burton, D. R., Parren, P. W., Ditzel, H. J., Kent, K. A., Arnold, C., Montefiori, D., and Hirsch, V. M. (1998). Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: Recovery from a long-term-nonprogressor SIV-infected macaque. J. Virol. 72, 585-592.
19. Hoffman, T., Stephens, E., Narayan, O., and Doms, R. (1998). HIV type 1 envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc. Natl. Acad. Sci. USA 75, 11360-11365.
20. Höhne, M., Thaler, S., Dudda, J. C., Groner, B., and Schnierle, B. S. (1999). Truncation of the immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. Virology 261, 70-78, doi:10.1006/viro.1999.9847.
21. Hwang, S. S., Boyle, T. J., Lyerly, H. K., and Cullen, B. R. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
22. + lymphoid cells. Gene Ther. 5, 209-217.
23. Javaherian, K., Langlois, A. J., Schmidt, S., Kaufmann, M., Cates, N., Langedijk, J. P., Meloen, R. H., Desrosiers, R. C., Burns, D. P., and Bolognesi, D. P. (1992). The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 1418-1422.
24. Javaherian, K., Langlois, A. J., Montefiori, D. C., Kent, K. A., Ryan, K. A., Wyman, P. D., Stott, J., Bolognesi, D. P., Murphey-Corb, M., and Larosa, G. J. (1994). Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J. Virol. 68, 2624-2631.
25. Kirchhoff, F., Morrison, H. G., Murray, M. G., Rennert, P., and Desrosiers, R. C. (1994a). SIVmac expressing hybrid envelope proteins containing HIV-1 V3 and/or C4 sequences is not competent for replication. AIDS Res. Hum. Retroviruses 10, 309-313.
26. Kirchhoff, F., Mori, K., and Desrosiers R. C. (1994b). The "V3" domain is a determinant of simian immunodeficiency virus cell tropism. J. Virol. 68, 3682-3692.
27. Kraus, G., Werner, A., Baier, M., Binniger, D., Ferdinand, F. J., Norley, S., and Kurth, R. (1989). Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys. Proc. Natl. Acad. Sci. USA 86, 2892-2896.
28. LaBranche, C. C., Hoffman, T. L., Romano, J., Haggarty, B. S., Edwards, T. G., Matthews, T. J., Doms, R. W., and Hoxie, J. A. (1999). Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J. Virol. 73, 10310-10319.
29. + peripheral blood lymphocytes. Gene Ther. 5, 655-664.
30. + cells. J. Virol. 71, 3341-3345.
31. Mamounas, M., Looney, D. J., Talbott, R., and Wong-Staal, F. (1995). An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinant. J. Virol. 69, 6424-6429.
32. Marx, P. A., and Chen, Z. (1998). The function of simian chemokine receptors in the replication of SIV. Semin. Immunol. 10, 215-223.
33. Meister, S., Otto, C., Papkalla, A., Krumbiegel, M., Pohlmann, S., and Kirchhoff, F. (2001). Basic amino acid residues in the v3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of cxcr4 as entry cofactor. Virology 284, 287-296, doi:10.1006/viro.2001.0852.
34. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J. M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M., and Moser, B. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T cell-line-adapted HIV-1. Nature 382, 833-583.
35. Olsen, J. C., and Sechelski, J. (1995). Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther. 6, 1195-202.
36. Ostrowski, M. A., Justement, S. J., Catanzaro, A., Hallahan, C. A., Ehler, L. A., Mizell, S. B., Kumar, P. N., Mican, J. A., Chun, T.-W., and Fauci A. S. (1998). Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 161, 3195-3201.
37. Overbaugh, J., Rudensey, L. M., Papenhausen, M. D., Benveniste, R. E., and Morton, W. R. (1991). Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65, 7025-7031.
38. Owen, S. M., Ellenberger, D., Rayfield, M., Wiktor, S., Michel, P., Grieco, M. H., Gao, F., Hahn, B. H., and Lal, R. B. (1998). Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J. Virol. 72, 5425-5432.
39. Owen, S. M., Masciotra, S., Novembre, F., Yee, J., Switzer, W. M., Ostyula, M., and Lal, R. B. (2000). Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells. J. Virol. 74, 702-708.
40. Pohlmann, S., Stolte, N., Munch, J, Ten Haaft, P., Heeney, J. L., Stahl-Hennig, C., and Kirchhoff, F. (1999). Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J. Infect. Dis. 180, 1494-1502.
41. Ross, T. M., and Cullen, B. R. (1998). The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop. Proc. Natl. Acad. Sci. USA 95, 7682-7686.
42. Sanes, J. R., Rubenstein, J. L., and Nicolas, J. F. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 3133-3142.
43. Sato, H., Kato, K., and Takebe, Y. (1999). Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop. Virology 257, 491-501, doi:10.1006/viro.1999.9670.
44. Sattentau, Q. J., and Moore, J. P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182, 185-196.
45. Schnierle, B. S., Stitz, J., Bosch, V., Nocken, F., Merget-Millitzer, H., Engelstädter, M., Kurth, R., and Cichutek, K. (1997). Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA 76, 8640-8645.
46. Schols, D., and De Clercq, E. J. (1998). The simian immunodeficiency virus mnd (GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells. Gen. Virol. 79, 2203-2205.
47. Shioda, T., Lavy, J. A., and Cheng-Mayer, C. (1992). Small amino acid changes in the V3 hypervariable region of gp120 can affect the T cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 9434-9438.
48. Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., and Kingsman, A. J. (1995). A transient three-plasmid expression system for the production of high-titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
49. Speck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B., and Goldsmith, M. A. (1997). Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71, 7136-7139.
50. Stitz, J., Müller, P., Merget-Millitzer, H., and Cichutek, K. (1998). High-titer retroviral pseudotype vectors for the specific targeting of human CD4-positive cells. Biog. Amines 14, 407-424.
51. Stitz, J., Steidl, S., Merget-Millitzer, H., König, R., Müller, P., Nocken, F., Engelstädter, M., Bobkova, M., Schmitt, I., Kurth, R., Buchholz, C. J., and Cichutek, K. (2000). MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralisation by sera from HIV-infected patients. Virology 267, 229-236, doi:10.1006/ viro.1999.0121.
52. Stratton, M. R., Darling, J., Pilkington, G. J., Lantos, P. L., Reeves, B. R., and Cooper, C. S. (1989). Characterization of the human cell line TE671. Carcinogenesis 10, 889-905.
53. Takeuchi, Y., Patience, C., Magre, S., Weiss, R. A., Banerjee, P. T., Le Tissier, P., and Stoye, J. P. (1998). Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72, 9986-9991.
54. Unutmaz, D., Xiang, W., Sunshine, M. J., Campbell, J., Butcher, E., and Littman, D. R. (2000). The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J. Immunol. 165, 3284-3292.
55. Vassiliadou, N., Tucker, L., and Anderson, D. J. (1999). Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J. Immunol. 162, 7510-7518.
56. Wilk, T., Pfeifer, T., and Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189, 167-177.
57. Wong-Staal, F., Gallo, R. C., Chang, N. T., Ghrayeb, J., Papas, T. S., Lautenberger, J. A., Pearson, M. L., Petteway, S. R.Jr., Ivanoff, L., Baumeister, K., Whitehorn, E. A., Rafalski, J. A., Doran, E. R., Josephs, S. J., Starcich, B., Livak, K. J., Patarca, R., Haseltine, W. A., and Ratner, L. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
58. Xiao, L., Owen, S. M., Goldman, I., Lal, A. A., deJong, J. J., Goudsmit, and J., Lal, R. B. (1998). CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 240, 83-92, doi:10.1006/viro.1997.8924.